TH178656B - Oncology pharmaceutical components and pharmaceutical preparations for Cancer treatment with the same components as active ingredients - Google Patents

Oncology pharmaceutical components and pharmaceutical preparations for Cancer treatment with the same components as active ingredients

Info

Publication number
TH178656B
TH178656B TH1601004171A TH1601004171A TH178656B TH 178656 B TH178656 B TH 178656B TH 1601004171 A TH1601004171 A TH 1601004171A TH 1601004171 A TH1601004171 A TH 1601004171A TH 178656 B TH178656 B TH 178656B
Authority
TH
Thailand
Prior art keywords
pharmaceutical
components
oncology
active ingredients
cancer treatment
Prior art date
Application number
TH1601004171A
Other languages
Thai (th)
Other versions
TH178656A (en
Original Assignee
ควอร์รี่เมน &Amp โคอิงค์
Filing date
Publication date
Application filed by ควอร์รี่เมน &Amp โคอิงค์ filed Critical ควอร์รี่เมน &Amp โคอิงค์
Publication of TH178656A publication Critical patent/TH178656A/en
Publication of TH178656B publication Critical patent/TH178656B/en

Links

TH1601004171A 2015-01-23 Oncology pharmaceutical components and pharmaceutical preparations for Cancer treatment with the same components as active ingredients TH178656B (en)

Publications (2)

Publication Number Publication Date
TH178656A TH178656A (en) 2018-08-09
TH178656B true TH178656B (en) 2018-08-09

Family

ID=

Similar Documents

Publication Publication Date Title
DK3616720T3 (en) PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT
HK1257373A1 (en) Dual function proteins and pharmaceutical composition comprising same
IL258854A (en) Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
IL258246B (en) Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer
IL255119A0 (en) Therapeutic pooled blood apoptotic cell preparations and uses thereof
GB201411465D0 (en) Active pharmaceutical ingredient (api) comprising cannabinoids for use in the treatment of cancer
IL253243A0 (en) Combined preparations for the treatment of cancer or infection
BR112016018062A2 (en) therapeutic compounds, pharmaceutical composition and uses
DK3532067T3 (en) LIPOSOMAL FORMULATION FOR USE IN THE TREATMENT OF CANCER
BR112016027043A2 (en) Combination, pharmaceutical composition comprising glucocorticoid and edo-s101, kit and use in cancer treatment
SG11201605868XA (en) Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient
TR201910866T4 (en) Combined preparations for cancer treatment.
HK1256674A1 (en) Deuterium-modified brigatinib derivatives, pharmaceutical compositions comprising same, and use thereof
WO2014121137A3 (en) Compositions and methods for the treatment of neurodegenerative and other diseases
IL266486A (en) Pharmaceutical compositions and methods for the treatment of cancer
EP3150212A4 (en) Pharmaceutical solution having anti-tumor effect-enhancing and toxicity-reducing effect, and pharmaceutical composition comprising same
ZA201900121B (en) Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same
DK3383872T3 (en) 1,3,4-THIADIAZOLIC COMPOUNDS AND ITS USE IN CANCER TREATMENT
IL274008A (en) Anti-msln antibody and pharmaceutical composition comprising same for cancer treatment
EP3398608A4 (en) Pharmaceutical composition for preventing and treating cancer or cancer metastasis, containing pstl1 protein as active ingredient
EP3290051A4 (en) Pharmaceutical composition for treating and/or preventing cancer
PL3262047T3 (en) Imidazopyrimidine and imidazotriazine derivatives and pharmaceutical compositions comprising the same
EP3563856A4 (en) Pharmaceutical composition for treating cancer and use thereof
IL249860A0 (en) Pharmaceutical compositions, methods for their preparation and their use in the treatment of cancer
EP3372233A4 (en) Pharmaceutical composition for treating and/or preventing cancer